Holds one active US DMF and 2 valid CEPs for dexamethasone, filing since 2022.
Holds one active US DMF for dexamethasone, filing since 2024. Its 2021 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 3 active US DMFs for dexamethasone, filing since 2004. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for dexamethasone, filing since 2024.
Holds 2 active US DMFs for dexamethasone, filing since 2022.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Dexamethasone manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free